Johannes Hallauer
Overview
Explore the profile of Johannes Hallauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
FitzSimons D, Hendrickx G, Hallauer J, Larson H, Lavanchy D, Lodewyckx I, et al.
Hepatol Med Policy
. 2018 Oct;
1:16.
PMID: 30288319
Hepatitis B is preventable and hepatitis C is treatable even if still at a high cost; most people who are infected with hepatitis B or C virus have not been...
2.
FitzSimons D, Kojouharova M, Hallauer J, Hendrickx G, Vorsters A, Van Damme P
Vaccine
. 2011 Sep;
29(47):8471-6.
PMID: 21951876
A meeting of the Viral Hepatitis Prevention Board in Sofia, Bulgaria on 24-25 March 2011 reviewed the burden and prevention of viral hepatitis in the country. It examined the organization...
3.
Kurz A, Wagenpfeil S, Hallauer J, Schneider-Schelte H, Jansen S
Int J Geriatr Psychiatry
. 2009 Dec;
25(8):861-9.
PMID: 19946869
Objective: To evaluate the efficacy of a practical, easily implemented, educational intervention in group format for informal carers of persons with dementia. Methods: Multi-centre, randomised, controlled, single-blind trial involving 292...
4.
5.
FitzSimons D, Francois G, Alpers K, Radun D, Hallauer J, Jilg W, et al.
Scand J Infect Dis
. 2005 Aug;
37(8):549-60.
PMID: 16099768
The Viral Hepatitis Prevention Board (VHPB) convened a meeting of international experts from the public and private sectors in the Nordic countries and Germany, in order to review the epidemiological...
6.
7.
Francois G, Hallauer J, Van Damme P
Vaccine
. 2002 Nov;
21(1-2):1-4.
PMID: 12443655
Current hepatitis B vaccination programmes targeting risk groups have met with little success in controlling HBV infection in the general population. Despite the long-standing existence of unambiguous recommendations for risk-group...